BEIJING (AP) - China has approved its first homegrown COVID-19 vaccine for general use, health regulators said Thursday, marking the addition of another vaccine in the global fight against a virus that is surging back in many places as winter sets in.The two-dose vaccine from state-owned Sinopharm is the first approved for general use in China.
The go-ahead comes shortly after the country launched a program to vaccinate 50 million people before the Lunar New Year holiday in February.